Skip to content

The Effect of Hypnotherapy on Pain Intensity in Endometriosis Patients Treated With Dinogest

Evaluation of the Effectiveness of Hypnotherapy on Pain Intensity in Endometriosis Patients Treated With Dinogest: A Randomized Controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110827007422N4
Enrollment
22
Registered
2021-09-18
Start date
2021-09-23
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Endometriosis. Condition 2: Pain. Condition 3: Quality of Life. Condition 4: Women's sexual function. Endometriosis

Interventions

Intervention 1: Intervention group: In Addition to the Routine Treatment, which Includes 2 mg of Dienogest Tablets Daily, Hypnotherapy in 8 Sessions, the First Session in Person and Individually and t

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women with Endometriosis (Confirmed by Laparoscopy or Laparotomy and Confirmed by Histology) Treated with Dynogest Married Women 45-18 Years Complaints of Painful Menstruation or Painful Intercourse or Pelvic Pain With a Minimum Score of 5 Cm on a Visual Analog Scale Pain at the Start of Treatment Having a Smartphone Internet Access

Exclusion criteria

Exclusion criteria: People With a History of Endometriosis Treatment With Surgery (Laparotomy, Llaparoscopy and Hysterectomy) History of Major or Minor Psychiatric Disorder in a First-Degree Individual or Family (Father, Mother, Sister, Brother, Child) People Who Currently Use Other Non-Pharmacological Methods to Reduce Pain (Such as: Yoga, Herbal Medicine, Acupressure, Acupuncture, Traditional Medicine, Biofeedback, etc.) Existence of Concomitant Cancer, Treatment of Anxiety or Uncontrolled Depression and Seizures

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before the iIntervention, Immediately After the Intervention, one Month After the Intervention. Method of measurement: VAS Pain Visual Scale Questionnaire.

Secondary

MeasureTime frame
Quality of Life. Timepoint: Before the Intervention, Immediately and one Month after the Intervention. Method of measurement: Endometriosis Quality of Life Questionnaire EHP-5.;Sexual Function. Timepoint: Before the Intervention, Immediately and one Month after the Intervention. Method of measurement: FSFI Women's Sexual Performance Index Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoja Shahriyaripoor

Mazandaran University of Medical Sciences

Rojashahriyaripoor1369@gmail.com+98 11 3337 4750

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026